Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
Appetite|June 9, 2009
Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagiaH V Morris, S Nilsson, C I Dixon, et al.Alcoholism, Clinical and Experimental Research|May 17, 2008
Alcohol induces DNA damage and the Fanconi anemia D2 protein implicating FANCD2 in the DNA damage response pathways in brainS L Rulten, E Hodder, T L Ripley, et al.Journal of Neural Transmission|January 1, 1986
Effect on hypothalamic self-stimulation of the novel beta-carbolines ZK 93 426 (a benzodiazepine receptor antagonist) and ZK 91 296 (a putative partial agonist)L J Herberg, A M Montgomery, S E File, et al.Neuropharmacology|February 1, 1995
Abecarnil enhances GABA-induced currents in acutely isolated cerebellar Purkinje cellsV S Vorobjev, I N Sharonova, V G Skrebitsky, et al.Genes, Brain, and Behavior|April 6, 2006
Sp1 and NFkappaB pathways are regulated in brain in response to acute and chronic ethanolS L Rulten, T L Ripley, C L Hunt, et al.The European Journal of Neuroscience|May 19, 2006
Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigmH V Morris, G R Dawson, D S Reynolds, et al.Brain Research Bulletin|September 1, 1987
Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacyD N Stephens, H H Schneider, W Kehr, et al.Gut|October 1, 1983
Histochemical changes in mucus in duodenal ulcerationS M Morrissey, P M Ward, A P Jayaraj, et al.Psychopharmacology|March 21, 2001
Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligandsJ Bergman, C P France, S G Holtzman, et al.Psychopharmacology|March 1, 1994
Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupanciesG H Jones, C Schneider, H H Schneider, et al.Pageof 12